Last reviewed · How we verify
Reduced Nicotine Content Cigarettes
At a glance
| Generic name | Reduced Nicotine Content Cigarettes |
|---|---|
| Also known as | Nicotine |
| Sponsor | Milton S. Hershey Medical Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Smart Olfaction App to Reduce Relapse (EARLY_PHASE1)
- Impact of Nicotine Messaging on Beliefs and Behavior (NA)
- Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women (PHASE1, PHASE2)
- Responses of Adults Smoking Nondaily and Daily in the Experimental Tobacco Marketplace (NA)
- Smoking Cessation Intervention for Cancer Patients (NA)
- The Impact of Innovative Tax Proposals on Purchase Patterns (NA)
- Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing (NA)
- Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |